Dear Sir/Madam, Please find the attached intimation under Regulation 57(4) of SEBI (LODR) Regulations, 2015. Thanking You.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has informed BSE and MSEI that it has not issued any non-convertible securities (such as NCDs or preference shares) for which interest, dividend, or principal repayment would be due during the October-December 2025 quarter. This is a routine compliance filing under SEBI LODR Regulation 57(4), which requires listed companies with such instruments to disclose upcoming payment obligations. By confirming a 'nil' position, the company is stating it has no such repayment or interest liability for the quarter.
This is a neutral, purely compliance-driven disclosure and is not expected to move the stock price. It simply confirms there are no NCD-related interest, dividend, or principal payments due from the company between October and December 2025.